GSK-1322322

CAS No. 1152107-25-9

GSK-1322322 ( Lanopepden;GSK-322 )

Catalog No. M10536 CAS No. 1152107-25-9

A novel antibacterial agent that targets bacterial peptide deformylase; demonstrates in vitro activity against MDR respiratory and skin infection pathogens.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    GSK-1322322
  • Note
    Research use only, not for human use.
  • Brief Description
    A novel antibacterial agent that targets bacterial peptide deformylase; demonstrates in vitro activity against MDR respiratory and skin infection pathogens.
  • Description
    A novel antibacterial agent that targets bacterial peptide deformylase; demonstrates in vitro activity against MDR respiratory and skin infection pathogens, including MDR Streptococcus pneumoniae and MRSA; inhibits S. pneumoniae ATCC 49619 with MIC of 0.12-0.5 ug/mL.
  • Synonyms
    Lanopepden;GSK-322
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    1152107-25-9
  • Formula Weight
    479.56
  • Molecular Formula
    C22H34FN7O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1=NC(=C(C(=N1)N2CCN3CCOCC3C2)F)NNC(=O)C(CC4CCCC4)CN(C=O)O
  • Chemical Name
    N-((R)-2-(cyclopentylmethyl)-3-(2-(5-fluoro-6-((S)-hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl)-2-methylpyrimidin-4-yl)hydrazinyl)-3-oxopropyl)-N-hydroxyformamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ross JE, et al. J Clin Microbiol. 2011 Nov;49(11):3928-30.
2. Arat S, et al. Antimicrob Agents Chemother. 2015 Feb;59(2):1182-92.
3. O'Dwyer K, et al. Antimicrob Agents Chemother. 2013 May;57(5):2333-42.
molnova catalog
related products
  • Ozenoxacin

    Ozenoxacin is a quinolone antibacterial. It shows potent activities against the main microorganisms isolated from soft tissue and skin infections.

  • Hexa-D-arginine TFA

    Hexa-D-arginine TFA (Furin Inhibitor II TFA) is an inhibitor of furin (Ki values are 0.106, 0.58 and 13.2 μM for furin, PACE4 and PC1 respectively).

  • PBP 10

    Selective formyl peptide receptor 2 (FPR2) antagonist; cell permeable. Selectively inhibits FPR2-mediated NADPH oxidase activity but has no effect on FPR1 signaling in neutrophils. Displays PIP2 binding activity in vitro and blocks cell motility. Also exhibits antiviral activity against influenza viruses via inhibition of viral-induced ERK activation.